Abstract
Over the past 50 years the challenge of schistosomiasis control has persisted as a complex dilemma for health policymakers- there has even been a debate about whether schistosomiasis has any significance to public health and whether it has priority for control. The major schistosome parasites of humans Schistosoma haematobium S. mansoni and S. japonicum are prevalent in many parts of Africa the Middle East South America China Southeast Asia and the Philippines and there are 1200 million people who are infected worldwide. The article by Koukounari et al. in this issue of the Journal is part of a modern multigroup research effort that aims to better define the impact of schistosomiasis on childrens health and to refine the understanding of the specific benefits of mass treatment in schistosomiasis-endemic settings. One of the particular strengths of the study is its large size and the broad distribution of its study subjects across the country of Burkina Faso. The study children were treated there as part of the ongoing Schistosomiasis Control Initiative (SCI). (excerpt)
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call